STING_IFN_CH25H lipid axis links innate immune activation to tau pathology
Chen, H.; Fan, L.; Wong, M. Y.; A. Ambaw, Y.; Zhu, J.; Norman, K.; Ye, P.; Foxe, N.; Zhu, D.; Wan, Y.; Srinivasan, M.; Mok, S.-A.; McIntire, L. B. J.; Walther, T. C.; Farese, R. V.; Gan, L.; Luo, W.
Show abstract
Genetic risk for Alzheimers disease is strongly enriched in pathways governing microglial activation and cholesterol metabolism, yet how these processes converge to drive neurodegeneration remains unclear. Here, we identify the oxysterol 25-hydroxycholesterol (25- HC) as a pathogenic lipid downstream of the cGAS-STING-IFN pathway. In models of tau pathology, interferon signaling induces Cholesterol 25-hydroxylase (CH25H) expression in microglia. Ch25h deletion in female P301S mice suppressed tau aggregation, preserved synapses, prevented brain atrophy, and rescued memory. Mechanistically, loss of CH25H disrupted STING trafficking, attenuated IFN activation, dampened self-perpetuating microglial inflammation. Strikingly, 25-HC directly accelerated tau propagation in human iPSC derived neurons. It also disrupted lysosomal and mitochondrial lipid composition, driving cholesteryl ester accumulation and promoting apoptosis under tau-induced stress. These findings define a STING-IFN-CH25H lipid axis that bridges innate immune activation to tau pathology and toxicity, offering a tractable therapeutic pathway for inflammation-driven neurodegenerative conditions.
Matching journals
The top 6 journals account for 50% of the predicted probability mass.
Similar papers in this journal
Similar papers in this journal
- β-Amyloid Induces Microglial Expression of GPC4 and APOE Leading to Increased Neuronal Tau Pathology and Toxicity 98%
- DAP12 deficiency alters microglia-oligodendrocyte communication and enhances resilience against tau toxicity 97%
- APOE Christchurch enhances a disease-associated microglial response to plaque but suppresses response to tau pathology 96%
Similar papers in this journal
- Triglyceride metabolism controls inflammation and APOE4-associated disease states in microglia 97%
- Natural genetic variation determines microglia heterogeneity in wild-derived mouse models of Alzheimer's disease 96%
- Single cell spatial transcriptomic and translatomic profiling of dopaminergic neurons in health, aging and disease 96%
Similar papers in this journal
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.